Planet Labs Tops Q1 FY27 Expectations and Raises FY Guidance; Gross Margin Compression Pressures Shares
Alpha Stocks Insight Staff
Independent stock news and analysis covering NASDAQ and NYSE markets.
Planet Labs beat Q1 FY27 revenue estimates with a record $94.2M (+42% YoY) and raised full-year guidance — but gross margin compression to 56% and a mixed profit profile sent shares lower after hours.
Planet Labs PBC (NYSE: PL) reported its fiscal first quarter 2027 financial results for the period ending April 30, 2026. The company delivered a top- and bottom-line beat alongside a raised full-year outlook. However, shares fell in after-hours trading as investors digested narrowing gross margins and an unfavorable mix shift toward lower-margin service revenue.
Q1 FY27 Financial Performance
- Revenue: Reached a record $94.2M, up 42% year-over-year, beating consensus estimates of $90.1M. Growth was primarily catalysed by a 65%+ surge in Defence and Intelligence segment demand.
- Adjusted EPS: Reported at -$0.03, outperforming the analyst consensus of -$0.04.
- Backlog & RPO: Total backlog expanded 72% YoY to $906M, while Remaining Performance Obligations grew 81% YoY to $816M, demonstrating robust visibility for mid-term revenue conversion.
- Balance Sheet: Cash, cash equivalents, and short-term investments stood at $730.8M (up 223% YoY), significantly bolstered by $107.8M in proceeds from public warrant exercises.
Gross Margin and Profitability Headwinds
Despite strong top-line momentum, non-GAAP gross margin contracted to 56% from 59% in the prior year period. This drop stems from initial service delivery execution, shifts in the partner mix, and rising depreciation costs linked to the Pelican satellite constellations. Management expects this structural margin compression to continue throughout the year, guiding full-year FY27 non-GAAP gross margins down to a range of 52% to 54%.
The company reported a GAAP net loss of $138.9M ($0.40/share) compared to a loss of $12.6M in Q1 FY26. However, this includes a non-operational $106.5M non-cash revaluation loss on warrant liabilities caused by recent stock price appreciation. Adjusted EBITDA loss landed at $1.0M, down slightly from a $1.2M profit in the prior year period.
Forward Guidance
Management raised its full-year targets, contrasting with initial market narratives of a guidance miss:
- Q2 FY27 Guidance: Revenue projected between $102M and $107M (midpoint $104.5M) vs. consensus of $100.9M. Adjusted EBITDA is expected to turn positive at $0M to $5M.
- Full-Year FY27 Guidance: Revenue raised to $425M–$441M (midpoint $433M), up from the previous view of $415M–$440M, and ahead of the $427.9M consensus. Full-year adjusted EBITDA guided to $0M–$10M.
Wall Street Consensus
Sell-side sentiment remains highly constructive. As of June 1, 2026, the consensus breakdown stood at 5 Strong Buy, 10 Buy, and 4 Hold ratings, with no Sell recommendations. While the long-term thematic growth story for geospatial intelligence remains intact, near-term price action will likely be dictated by how quickly management can transition its high-margin AI analytics offerings to offset structural hardware depreciation.
Investor Takeaway
The central tension for PL is no longer demand — which is well-validated by the $906M backlog — but unit economics. The market is reacting to the realisation that accelerating government defence contracts and AI-enabled partner solutions carry a less profitable margin profile than pure-play Data-as-a-Service subscriptions. While the top-line guidance raise proves operational execution is strong, the stock may remain range-bound until gross margins stabilise and confirm a clear path toward sustainable GAAP operating leverage.
Related Articles
C3.ai (NYSE:AI) Q4 FY2026: Revenue Plunges 29%, CEO Flags Sales Miss
Broadcom (AVGO) Reports Q2 EPS of $2.44, Issues Q3 Guidance Above Consensus
Medtronic (MDT) Posts Strongest Top-Line Quarter in a Decade in Q4 FY2026
Ulta Beauty (NASDAQ: ULTA) Beats Q1 2026 Estimates, Plans Times Square Flagship
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.